[Aplastic anemia as a consequence of chloramphenicol treatment].
D000328:Adult; D000367:Age Factors; D000741:Anemia, Aplastic / Q000139:chemically induced*; D000818:Animals; D002701:Chloramphenicol / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D004920:Erythropoiesis / Q000187:drug effects; D005260:Female; D006207:Half-Life; D006413:Hematopoietic System / Q000187:drug effects; D006454:Hemoglobins / Q000096:biosynthesis; D006801:Humans; D008297:Male; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008930:Mitochondria, Liver / Q000187:drug effects; D011817:Rabbits; D013997:Time Factors; D014435:Typhoid Fever / Q000188:drug therapy
D006454:Hemoglobins; D002701:Chloramphenicol
Niedokrwistość aplastyczna jako nastepstwo stosowania chloramfenikolu